In vitro comparative assessment of β-lactamase inhibitors and their penicillin combinations against selected enterobacteria

International Journal of Antimicrobial Agents

Volumn 8, Issue 3, 1997, Pages 193-197

  Tzouvelekis, L S ^a   Zissis, N P ^b   Gazouli, M ^a   Tzelepi, E ^a   Legakis, N J ^c  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

^b Research Department   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

lactam resistance; lactamase inhibitors; Enterobacteria

Indexed keywords

AMOXICILLIN; AMPICILLIN; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CEFALORIDINE; CEFALOTIN; CEFOTAXIME; CEFOXITIN; CEPHALOSPORINASE; CLAVULANIC ACID; NITROCEFIN; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN; SULBACTAM; TAZOBACTAM; TICARCILLIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; CITROBACTER FREUNDII; CONTROLLED STUDY; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ENZYME INDUCTION; ENZYME INHIBITION; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SERRATIA MARCESCENS;

EID: 0030970701     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(97)00372-5     Document Type: Article

References (14)

1. Greek Society for Microbiology. Antibiotic resistance among gram-negative bacilli in 19 Greek hospitals. J Hosp Infect 1989;14:169-171.
2. Legakis NJ, Tzouvelekis LS, Tsakris A, Legakis JN, Vatopoulos AC. On the incidence of antibiotic resistance among Gram negative rods isolated in Greek hospitals. J Hosp Infect 1993;34:233-237.
3. Legakis NJ, Maniatis A, Tzouvelekis LS. Prevalent mechanisms of resistance among common enterobacterial isolates in Greek hospitals. Bacter Drug Resist 1996;1:285-287.
4. Tzelepi E, Tzouvelekis LS, Vatopoulos AC, Mentis A, Tsakris A, Legakis NJ. High prevalence of stably derepressed class-I β-lactamase expression in multiresistant clinical isolates of Enterobacter cloacae from Greek hospitals. J Med Microbiol 1992;37:91-95.
5. Matthew M, Harris AM, Marshall MJ, Ross GW. The use of analytical isoelectric focusing for detection and identification of β-lactamases. J Gen Microbiol 1975;88:169-178.
6. O'Callaghan CH, Muggleton PW, Ross GW. Effects of β-lactamases from gram-negative organisms on cephalosporins and penicillins. In: Hobby GL (ed) Antimicrobial Agents Chemotherapy. American Society for Microbiology Bethesda, MD, 1968;57-63.
7. Papanicolaou G, Medeiros A, Jacoby G, Novel plasmid-mediated β-lactamase (MIR-1) conferring resistance to oxyimino-and α-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 1990;34:2200-2209.
8. Legakis NJ, Tzouvelekis LS, Hatzoudis G, et al. Dissemination of plasmids encoding an SHV-5 type β-lactamase among Klebsiella pneumoniae strains isolated in Greek hospitals. J Hosp Infect 1995;31:177-187.
9. Prinarakis EE, Tzelepi E, Gazouli M, Mentis AF, Tzouvelekis LS. Characterization of a novel SHV β-lactamase variant that resembles the SHV-5 enzyme. FEMS Microbiol Lett 1996;139:229-234.
10. Gazouli M, Tzouvelekis LS, Prinarakis E, Tzelepi E. Transferable cefoxitin resistance in enterobacteria isolated in Greek hospitals and characterization of a plasmid-mediated group 1 β-lactamase (LAT-2). Antimicrob Agents Chemother 1996;40:1736-1740.
11. Livermore DM. β-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995;8:557-584.
12. Moosdeen F, Keeble J, Williams JD. Induction/inhibition of chromosomal β-lactamases by β-lactamase inhibitors. Rev Infect Dis 1986;8(Suppl. 5):562-568.
13. Marshall SA, Aldridge KE, Allen SD, Fuchs PC, Gerlach EH, Jones RN. Comparative antimicrobial activity of piperacillin-tazobactam tested against more than 5000 recent clinical isolates from five medical centers. A re-evaluation after five years. Diagn Microbiol Infect Dis 1995;21:153-168.
14. Chow JW, Fine MJ, Shlaes DM, et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991;115:585-590.